IBDEI10V ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16621,2)
 ;;=^5001356
 ;;^UTILITY(U,$J,358.3,16622,0)
 ;;=C78.01^^61^775^163
 ;;^UTILITY(U,$J,358.3,16622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16622,1,3,0)
 ;;=3^Malig Neop Right Lung,Secondary
 ;;^UTILITY(U,$J,358.3,16622,1,4,0)
 ;;=4^C78.01
 ;;^UTILITY(U,$J,358.3,16622,2)
 ;;=^5001335
 ;;^UTILITY(U,$J,358.3,16623,0)
 ;;=C79.70^^61^775^114
 ;;^UTILITY(U,$J,358.3,16623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16623,1,3,0)
 ;;=3^Malig Neop Adrenal Gland Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,16623,1,4,0)
 ;;=4^C79.70
 ;;^UTILITY(U,$J,358.3,16623,2)
 ;;=^5001355
 ;;^UTILITY(U,$J,358.3,16624,0)
 ;;=C78.00^^61^775^147
 ;;^UTILITY(U,$J,358.3,16624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16624,1,3,0)
 ;;=3^Malig Neop Lung Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,16624,1,4,0)
 ;;=4^C78.00
 ;;^UTILITY(U,$J,358.3,16624,2)
 ;;=^5001334
 ;;^UTILITY(U,$J,358.3,16625,0)
 ;;=D57.1^^61^775^191
 ;;^UTILITY(U,$J,358.3,16625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16625,1,3,0)
 ;;=3^Sickle-Cell Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,16625,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,16625,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,16626,0)
 ;;=D75.1^^61^775^189
 ;;^UTILITY(U,$J,358.3,16626,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16626,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,16626,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,16626,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,16627,0)
 ;;=C90.30^^61^775^202
 ;;^UTILITY(U,$J,358.3,16627,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16627,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,16627,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,16627,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,16628,0)
 ;;=D56.3^^61^775^203
 ;;^UTILITY(U,$J,358.3,16628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16628,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,16628,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,16628,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,16629,0)
 ;;=D56.9^^61^775^204
 ;;^UTILITY(U,$J,358.3,16629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16629,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,16629,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,16629,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,16630,0)
 ;;=D51.2^^61^775^207
 ;;^UTILITY(U,$J,358.3,16630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16630,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,16630,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,16630,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,16631,0)
 ;;=D05.92^^61^775^40
 ;;^UTILITY(U,$J,358.3,16631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16631,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,16631,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,16631,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,16632,0)
 ;;=D05.91^^61^775^42
 ;;^UTILITY(U,$J,358.3,16632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16632,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,16632,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,16632,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,16633,0)
 ;;=D05.90^^61^775^38
 ;;^UTILITY(U,$J,358.3,16633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16633,1,3,0)
 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
 ;;^UTILITY(U,$J,358.3,16633,1,4,0)
 ;;=4^D05.90
 ;;^UTILITY(U,$J,358.3,16633,2)
 ;;=^5001935
 ;;^UTILITY(U,$J,358.3,16634,0)
 ;;=D51.0^^61^775^208
